IT1286183B1 - Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions - Google Patents

Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions

Info

Publication number
IT1286183B1
IT1286183B1 ITFI940039A IT1286183B1 IT 1286183 B1 IT1286183 B1 IT 1286183B1 IT FI940039 A ITFI940039 A IT FI940039A IT 1286183 B1 IT1286183 B1 IT 1286183B1
Authority
IT
Italy
Prior art keywords
relaxin
gestosis
eclampsia
arteriosclerosis
pregnancy
Prior art date
Application number
Other languages
Italian (it)
Inventor
Mario Bigazzi
Original Assignee
Mario Bigazzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Bigazzi filed Critical Mario Bigazzi
Priority to ITFI940039 priority Critical patent/IT1286183B1/en
Publication of ITFI940039A0 publication Critical patent/ITFI940039A0/en
Priority to DE69434777T priority patent/DE69434777T2/en
Priority to US08/403,878 priority patent/US5952296A/en
Priority to PCT/IT1994/000124 priority patent/WO1995003822A2/en
Priority to EP94923052A priority patent/EP0675732B1/en
Priority to CA002145515A priority patent/CA2145515A1/en
Publication of ITFI940039A1 publication Critical patent/ITFI940039A1/en
Application granted granted Critical
Publication of IT1286183B1 publication Critical patent/IT1286183B1/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Use of relaxin (I) in the treatment of circulatory ischemic diseases is new.
ITFI940039 1993-07-27 1994-02-25 Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions IT1286183B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI940039 IT1286183B1 (en) 1994-02-25 1994-02-25 Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions
DE69434777T DE69434777T2 (en) 1993-07-27 1994-07-26 Use of relaxin for the preparation of therapeutic agents
US08/403,878 US5952296A (en) 1993-07-27 1994-07-26 Method of using relaxin as therapeutic or preventing agent
PCT/IT1994/000124 WO1995003822A2 (en) 1993-07-27 1994-07-26 Use of relaxin as therapeutic or preventing agent
EP94923052A EP0675732B1 (en) 1993-07-27 1994-07-26 Use of relaxin in the manufacture of therapeutic agents
CA002145515A CA2145515A1 (en) 1993-07-27 1994-07-26 Use of relaxin as therapeutic or preventing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI940039 IT1286183B1 (en) 1994-02-25 1994-02-25 Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions

Publications (3)

Publication Number Publication Date
ITFI940039A0 ITFI940039A0 (en) 1994-02-25
ITFI940039A1 ITFI940039A1 (en) 1995-08-25
IT1286183B1 true IT1286183B1 (en) 1998-07-07

Family

ID=11350767

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI940039 IT1286183B1 (en) 1993-07-27 1994-02-25 Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions

Country Status (1)

Country Link
IT (1) IT1286183B1 (en)

Also Published As

Publication number Publication date
ITFI940039A1 (en) 1995-08-25
ITFI940039A0 (en) 1994-02-25

Similar Documents

Publication Publication Date Title
AU594488B2 (en) Agents for the treatment of arthroses
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
ZA88798B (en) Dental anti-plaque and anti-caries agent
NO943473D0 (en) "Freezer" piece with the skin's pH and process for its preparation
CA2195093A1 (en) Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
DE69512685D1 (en) AGENTS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO OR THROUGH THE SKIN
AU2159092A (en) Use of lysophosphate acids for the treatment of skin wrinkles
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
AU2219795A (en) Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease
UA32542C2 (en) method and device for continuous moistening of friable foodstuffs and fodders
IT8419730A0 (en) PROCEDURE FOR THE QUANTITATIVE TRANSFORMATION OF TEICOPLANIN A2 FACTOR 1 INTO TEICOPLANIN A2 FACTOR 3.
IE873124L (en) Agent for the regulation of the appetite or a sleeping agent
NZ306443A (en) Vaccine for treating chlamydia comprising momp protein from chlamydia in conjunction with 3d-mpl and qs21
WO1990013643A3 (en) Glycoprotein hormone receptor molecules
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
IT1286182B1 (en) Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions
IT1286183B1 (en) Relaxin useful as wide ranging medicament for circulatory disorders - e.g. arteriosclerosis, eclampsia and gestosis of pregnancy, and for NO and atrial natriuretic peptide modulated conditions
ZA929390B (en) The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects.
IT8420213A0 (en) PROCEDURE FOR THE PREPARATION OF 1,8-DIHYDROXY-10-ACYL-9-ANTHRONES, PARTICULARLY FOR USE IN THE TREATMENT OF PSORIASIS.
PL336662A1 (en) Tissular factor producing a blood vesell formation effect
AU5728494A (en) Anti-edlf antibody, composition thereof and method of diagnosing and treating cardiac arrhythmias, hypertension
AU7078298A (en) Method for the diagnosis, treatment and prophylaxis of premature ejaculation andcatheter for the diagnosis, treatment and prophylaxis of premature ejaculation
NO984965D0 (en) Component B as cicatrisant
NZ333652A (en) Inhibition of human rotavirus infection using kappa-casein
IT9048106A0 (en) MEDICINAL ASSOCIATION FOR THE TREATMENT OF HYPERTENSION AND CONGESTIVE HEART FAILURE. (CASE 100-7516)

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990225